Incidence of Ocular Hemorrhages in Anticoagulated Patients Receiving Repeated Intravitreal Injections

American Journal of Ophthalmology

Volumn 145, Issue 2, 2008, Pages 386-387

  Meyer, Carsten H ^a   Eter, Nicole ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BEVACIZUMAB; PEGAPTANIB; TRIAMCINOLONE; VASCULOTROPIN ANTIBODY; WARFARIN;

ANTICOAGULANT THERAPY; HUMAN; INTRAOCULAR HEMORRHAGE; LETTER; PRIORITY JOURNAL; RETINA DISEASE; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; RETINAL THROMBOSIS; SUBMACULAR HEMORRHAGE; THROMBOSIS; VITREOUS HEMORRHAGE;

ANGIOGENESIS INHIBITORS; ANTICOAGULANTS; APTAMERS, NUCLEOTIDE; ASPIRIN; CHOROIDAL NEOVASCULARIZATION; DRUG THERAPY, COMBINATION; EYE HEMORRHAGE; HUMANS; INCIDENCE; INJECTIONS; MACULAR DEGENERATION; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY; WARFARIN;

EID: 38349161126     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.10.008     Document Type: Letter

References (5)

1. Dayani P.N., Siddiqi O.K., and Holekamp N.M. Safety of intravitreal injections in patients receiving warfarin anticoagulation. Am J Ophthalmol 14 (2007) 451-453
2. Meyer C.H., Callizo J., Mennel S., and Kussin A. Perioperative management of anticoagulated patients undergoing repeated intravitreal injections. Arch Ophthalmol 125 (2007) 994
3. Gupta R., Negi A., and Vernon S.A. Severe subconjunctival hemorrhage following intravitreal triamcinolone for refractory diabetic oedema. Eye 19 (2005) 590-591
4. Fung A.E., Rosenfeld P.J., and Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90 (2006) 1344-1349
5. Charles S., Rosenfeld P.J., and Gayer S. Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections. Retina 27 (2007) 813-815